At baseline, both IFN scores were elevated in those at-risk who progressed to connective tissue diseases at 12 months versus nonprogressors, to a greater extent for IFN-Score-B (3.22-fold difference) than IFN-Score-A (2.94-fold difference). Here, IFNA1 is linked to connective tissue disorder.